Investor Registration Form HIHR-7, November 2020

To register for HIHR-7 please fill out the form below

√ data shared with fellow participants, upon approval
* required

Investor Registration Form HIHR-7 November 2020
Gender √
I will join as: *
Is the billing address same as above? *
I will join HIHR. In addition to me, the following colleagues listed below, would also like to join. They will sign up separately to mark their interest in QF-sessions and receive the invite for the various online sessions. NB their names are needed to ensure only one invoice will be sent to your company. *
I am interested in (more options possible): *
I'm happy to contribute to: *

Please mark your interest in the following 4 Quickfire sessions, preferably November 1 the latest (for planning purposes). After November 1, allocation will be based on availability.

1. Immuno-oncology spin-off company *
Targeted anti-cancer therapy via engineered antigen presenting polymers
Therapeutics & Biotech, Oncode Institute
QF session: Monday 9 November 09.00 - 09.45
2. Preimure, automated antibacterial coatings to prevent implant-related infection *
To progress different tuneable and bio-stable coatings that could be tailored based on patient demands.
Therapeutics & Biotech - UMC Utrecht
QF session: Monday 9 November, 12.00 - 12.45
3. Technology for drugging the ‘undruggable’ protein targets inside cells *
By using our bodies own natural nanocarriers.
Therapeutics & Biotech - Utrecht Holdings
QF session: Monday 9 November 17.00 - 17.45
4. THERAtRAME, matching your drugs to patients. *
Drug positioning, drug discovery optimization, clinical trial design
eHealth & Datascience - ULiège
QF session: Tuesday 10 November, 17.00 - 17.45

Please mark your interest for the additional QF-sessions, following their pitch sessions, if you want to be secured of a seat.

5. GOAL 3 - automated monitoring solutions *
AI enhanced monitoring solutions for early detection of critical illness
Medtech & Diagnostics - Amsterdam AMC
QF session: Thursday 12 November 09.00 - 09.45
6. Phosphoenix *
Prothesis in visual cortex of blind people to restore vision
MedTech & Diagnostics - KNAW
QF session: Thursday 12 November, 12.00 - 12.45
7. REHAL-IT *
Help software for the diagnosis and rehabilitation of cognitive disorders
Therapeutics & Biotech - ULB
QF session: Thursday 12 November 17.00 - 17.45
8. River BioMedics *
We develop and provide advanced human 3D cardiac models for drug discovery
Therapeutics & Biotech - UTwente
QF session: Friday 13 November 09.00 - 09.45
9. Vascoscope *
Point-of-care vascular access made easy
MedTech & Diagnostics - Utrecht Holdings
QF session: Friday 13 November, 12.00 - 12.45
10. XPECT-INX a bioink company *
Bioinks” are materials to enable 3D-printing of cells and tissues
Therapeutics & Biotech - UGent
QF session: Friday 13 November 17.00 - 17.45
11. Gelgraft Medical *
The solution towards minimally invasive breast reconstruction
Therapeutics & Biotech - UGent
QF session: Monday 16 November 09.00 - 09.45
12. DepistEye *
Early screening test for Autism Spectrum Disorder
MedTech & Diagnostics - ULB
QF session: Monday 16 November, 12.00 - 12.45
13. 2ndB *
The brain-on-a-chip company
Therapeutics & Biotech - TU Eindhoven
QF session: Monday 16 November 17.00 - 17.45
I agree to share my/our contact details (√) with fellow participants *
I agree to store my/our contact details (√) and use for next HIHR editions *

Thank you for completing this form. You will receive a confirmation shortly. We look forward to welcoming you to our online sessions in November.

By submitting this form, I agree to the invoicing of the participation fee a €200 for VCs, resp. €100 for Entrepreneurs (all amounts ex VAT). Only one invoice will be sent per organisation.

 

 

 

Participating academic institutions in the Benelux, incl their UMC's

Radboud umc
Wageningen University & Research

Preferred partner

Silver partners

LC Patents - Arnold & Siedsma

HIHR supporters

V-Bio Ventures | Novalis II | NLC Health | Thuja | Bioqube Ventures